Summary by Futu AI
David Christopher Mehlin, the Chief Operating Officer of Novo Integrated Sciences, Inc., has engaged in a transaction involving the company's stock on January 16, 2024. The transaction pertained to Class A Common Stock, with Mehlin directly holding a total of 8,195 shares after the event. The action reflects changes in the direct holdings of the company's securities by a key executive and is relevant for current and potential investors monitoring insider activity.